Sonam Puri MD (@sonampuri) 's Twitter Profile
Sonam Puri MD

@sonampuri

Thoracic oncologist and clinical research medical director at @moffittresearch| Dog mom. Views are my own

ID: 283356214

calendar_today17-04-2011 04:00:57

286 Tweet

1,1K Takipçi

712 Takip Edilen

Jill Feldman (@jillfeldman4) 's Twitter Profile Photo

My fam history illustrates hope/progress in #lungcancer. My parents died mths after being dx - I’ve lived 14 yrs bc of advances in research! #Researchmatters! It’s our lifeline, future & future of our children. The true value of #research for patients & families is HOPE! #LCSM

Dr. Estela Rodriguez (@latinamd) 's Twitter Profile Photo

You never know who you will meet next - but it was not a surprise to bump into all these amazing ASCO volunteer leaders at HQ today -who are making a difference in the lives of patients w cancer. Dr. Luis E. Raez Ivy Riano, M.D. Enrique Soto Sonam Puri MD Conquer Cancer, the ASCO Foundation

You never know who you will meet next - but it was not a surprise to bump into all these amazing <a href="/ASCO/">ASCO</a> volunteer leaders at HQ today -who are making a difference in the lives of patients w cancer. 

<a href="/LuisRaezMD/">Dr. Luis E. Raez</a> <a href="/IvyLorena_Md/">Ivy Riano, M.D.</a> <a href="/EnriqueSoto8/">Enrique Soto</a> <a href="/Sonampuri/">Sonam Puri MD</a> <a href="/ConquerCancerFd/">Conquer Cancer, the ASCO Foundation</a>
Sonam Puri MD (@sonampuri) 's Twitter Profile Photo

Cannot think of a better person than Jhanelle Gray MD for the ASCO board of director nom. Her exceptional leadership skills & devotion have made a significant impact in advancing cancer care. Let's unite in supporting her vision for a stronger, patient-centered future in oncology!!

Ivy Elkins (@ivybelkins) 's Twitter Profile Photo

10 years ago on 12/26, I was diagnosed with stage IV #EGFR+ #lungcancer. I’m still here thanks to research and making memories with my family! #lcsm EGFR Resisters

10 years ago on 12/26, I was diagnosed with stage IV #EGFR+ #lungcancer. I’m still here thanks to research and making memories with my family! #lcsm <a href="/EGFRResisters/">EGFR Resisters</a>
Journal for ImmunoTherapy of Cancer (@jitcancer) 's Twitter Profile Photo

Countdown to 2024: #JITCTop10 - Real-world pan-cancer landscape of frameshift mutations and their role in predicting responses to immune checkpoint inhibitors in cancers with low tumor mutational burden bit.ly/3L6VQ75 Vaia Florou, MD Asaf Maoz Rafeh Naqash, MD Sonam Puri MD

Countdown to 2024: #JITCTop10 - Real-world pan-cancer landscape of frameshift mutations and their role in predicting responses to immune checkpoint inhibitors in cancers with low tumor mutational burden bit.ly/3L6VQ75 <a href="/VaiaFlorou/">Vaia Florou, MD</a> <a href="/asaf_maoz/">Asaf Maoz</a> <a href="/thenasheffect/">Rafeh Naqash, MD</a> <a href="/Sonampuri/">Sonam Puri MD</a>
Sonam Puri MD (@sonampuri) 's Twitter Profile Photo

Excited to be at the DAVA Oncology lung cancer conference in beautiful Kona, Hawaii with my amazing thoracic oncology team! Enjoying the sunshine and waves while discussing groundbreaking research. Moffitt Cancer Center Jhanelle Gray MD Ben Creelan, MD #LetsTalkAboutLungCancers #DAVALung ---

Excited to be at the <a href="/DAVAOnc/">DAVA Oncology</a> lung cancer conference in beautiful Kona, Hawaii with my amazing thoracic oncology team! 
Enjoying the sunshine and waves while discussing groundbreaking research. 
<a href="/MoffittNews/">Moffitt Cancer Center</a> <a href="/JhanelleGray/">Jhanelle Gray MD</a> <a href="/BenCreelan/">Ben Creelan, MD</a> 
#LetsTalkAboutLungCancers
#DAVALung 

---
Sonam Puri MD (@sonampuri) 's Twitter Profile Photo

Kicking off Day 2 of #WCLC2024 with the wonderful Rayzebio team! Excited to present early results from the RYZ101-101 study in a poster session today, featuring the first-in-class, alpha-emitting, SSTR2-targeting radiopharmaceutical RYZ-101 in patients with SCLC Moffitt Cancer Center

Kicking off Day 2 of #WCLC2024 with the wonderful Rayzebio team! Excited to present early results from the RYZ101-101 study in a poster session today, featuring the first-in-class, alpha-emitting, SSTR2-targeting radiopharmaceutical RYZ-101 in patients with SCLC <a href="/MoffittNews/">Moffitt Cancer Center</a>
Sonam Puri MD (@sonampuri) 's Twitter Profile Photo

The inspiring Judy Johnson delivering a powerful talk on patient perspectives in SCLC. While new advances bring hope, there’s a critical need to make trials more accessible& feasible. Equally important is keeping trial participants informed about study progress. #WCLC2024 #swog

The inspiring Judy Johnson delivering a powerful talk on patient perspectives in SCLC. While new advances bring hope, there’s a critical need to make trials more accessible&amp; feasible. Equally important is keeping trial participants informed about study progress. #WCLC2024 #swog
Chul Kim (@chulkimmd) 's Twitter Profile Photo

Phase I trial of DLL3/CD3 T-cell engager Obrixtamig in DLL3+ tumors ORR in all pts receiving at least 90 ug/kg = 28% ORR in LCNEC-L = 70% (n=10) Exciting activity! #WCLC24

Phase I trial of DLL3/CD3 T-cell engager Obrixtamig in DLL3+ tumors

ORR in all pts receiving at least 90 ug/kg = 28%

ORR in LCNEC-L = 70% (n=10)

Exciting activity!

#WCLC24
Dr. Estela Rodriguez (@latinamd) 's Twitter Profile Photo

#ASCOSAdvocacySummit Capitol Hill Legislative Trainning this morning. Florida delegation ready to speak to legislators about ASCO bipartisan priorities: ✅NIH Cancer Research ✅Prior Authorization Bill ✅Cancer Drug Shortages #physicianadvocates #beatthetable

#ASCOSAdvocacySummit Capitol Hill Legislative Trainning this morning. 

Florida delegation ready to speak to legislators about <a href="/ASCO/">ASCO</a> bipartisan priorities:
✅NIH Cancer Research
✅Prior Authorization Bill
✅Cancer Drug Shortages

#physicianadvocates #beatthetable
Sonam Puri MD (@sonampuri) 's Twitter Profile Photo

Thanks, ASCO for naming me an Advocacy Champion for my continued commitment to advocating for issues affecting the #oncology community. You can be an Advocacy Champion too by getting involved today: asco.org/actnetwork #ASCOAdvocacySummit

Thanks, <a href="/ASCO/">ASCO</a> for naming me an Advocacy Champion for my continued commitment to advocating for issues affecting the #oncology community. You can be an Advocacy Champion too by getting involved today: asco.org/actnetwork #ASCOAdvocacySummit
Sonam Puri MD (@sonampuri) 's Twitter Profile Photo

Team Florida at the hill today! Thanks to the lovely #ASCOAdvocacy team for bringing oncology representatives from Tampa , Miami , Gainesville , Jacksonville, Naples and Tallahassee together to support issues affecting cancer care ASCO

Moffitt Cancer Center (@moffittnews) 's Twitter Profile Photo

Happening now at #ASCO25: Moffitt’s Sonam Puri, MD, (Sonam Puri MD) leads a case based panel on navigating emerging therapeutic decisions in the treatment of #NSCLC. Key points: 👉First line therapy is rapidly evolving: • Chemoimmunotherapy is the current standard of care for

Happening now at #ASCO25: Moffitt’s Sonam Puri, MD, (<a href="/Sonampuri/">Sonam Puri MD</a>) leads a case based panel on navigating emerging therapeutic decisions in the treatment of #NSCLC.

Key points:
👉First line therapy is rapidly evolving:
• Chemoimmunotherapy is the current standard of care for
Dr. Iván R. González (@dr_ivanoncologo) 's Twitter Profile Photo

🎉 Congratulations to Sonam Puri MD for leading the insightful panel: "Navigating Emerging Therapeutic Decisions in the Treatment of Small Cell Lung Cancer: Cases and Considerations" 🌟 Objective: Explore emerging therapeutic options and decision-making in SCLC care. 📊 Key

🎉 Congratulations to <a href="/Sonampuri/">Sonam Puri MD</a>  for leading the insightful panel: "Navigating Emerging Therapeutic Decisions in the Treatment of Small Cell Lung Cancer: Cases and Considerations"

🌟 Objective: Explore emerging therapeutic options and decision-making in SCLC care.
📊 Key